accediregister

carrello

0.00 €
Testato HPLCCOA ogni lottoSpedizione UESEPA · pagamento sicuroSolo uso di ricerca
PEPTIQA BIOTECHTesamorelin10 mgPurity 8% · RUO

Excellent

Ocena 4.8 / 5 — zgodnja ocena kakovosti

★Peptiqa Reviews

Zgodnja ocena kakovosti — po prvem verified nakupu lahko kupci objavijo mnenje.

Tesamorelin

10 mg8% purityLot #TESAMO-2026-001

SKU della dimensione selezionata: PEP-TESA-10MG

Tesamorelin is a synthetic peptide composed of 44 amino acids and represents a modified analog of growth hormone-releasing hormone (GHRH). A trans-3-hexenoic acid moiety has been added to its N-terminal region, enhancing its stability and prolonging its biological half-life compared with endogenous GHRH. Marketed as Egrifta® and Egrifta SV®, it remains the only FDA-approved GHRH analog specifically authorized for the treatment of excess visceral abdominal fat in adults affected by HIV-associated lipodystrophy. Through selective stimulation of growth hormone secretion from the pituitary gland, Tesamorelin primarily reduces deep visceral adipose tissue while helping preserve both subcutaneous fat stores and lean body mass. Large randomized controlled trials have consistently demonstrated reductions in abdominal trunk fat and waist circumference, along with improvements in patient body image, without many of the adverse effects commonly associated with direct HGH administration.
€201.30incl. VAT
✅ Disponibile (40)

Prezzi per volume

QuantitàPrezzo unitarioRisparmio
1 vial201.30 €—
3 vials (−7%)186.66 €−7%
5 vials (−12%)176.90 €−12%
Nakup & zberi 165 točk!

Ocene in mnenja

Prijavite se in ocenite izdelek po prejetem naročilu. accedi

Certificato di analisi

Verificato in lab
✓Visualizza COA prima dell'acquisto — trasparenza garantita
Profilo di ricerca

Tesamorelin — profilo scientifico

Il contenuto è destinato a scopi educativi e di ricerca. Research Use Only.

  • Tesamorelin is a synthetic peptide composed of 44 amino acids and represents a modified analog of growth hormone-releasing hormone (GHRH). A trans-3-hexenoic acid moiety has been added to its N-terminal region, enhancing its stability and prolonging its biological half-life compared with endogenous GHRH. Marketed as Egrifta® and Egrifta SV®, it remains the only FDA-approved GHRH analog specifically authorized for the treatment of excess visceral abdominal fat in adults affected by HIV-associated lipodystrophy.
  • Through selective stimulation of growth hormone secretion from the pituitary gland, Tesamorelin primarily reduces deep visceral adipose tissue while helping preserve both subcutaneous fat stores and lean body mass. Large randomized controlled trials have consistently demonstrated reductions in abdominal trunk fat and waist circumference, along with improvements in patient body image, without many of the adverse effects commonly associated with direct HGH administration.

Altro da GH peptidi

BPC-157
BPC-157
€114.68
TB-500
TB-500
€119.56
Glutathione
Glutathione
€87.84
GHK-Cu
GHK-Cu
€103.70

This site uses cookies

Accept